Patents Assigned to Vide Pharmaceuticals
  • Methods and compositions for ATP-sensitive K.sup.+ channel inhibition for lowering intraocular pressure
    Patent number: 5965620
    Abstract: ATP-sensitive K.sup.+ channel modulating compounds are incorporated into ophthalmically acceptable carriers for administration to the eye in order to affect intraocular pressure. Such formulations including compounds which inhibit the channel are particularly suitable for treating glaucoma and other disorders related to elevated intraocular pressure. Such formulation which potentiates the channel are particularly suitable for treating hypotonia and other depressed intraocular pressure conditions.
    Type: Grant
    Filed: August 8, 1997
    Date of Patent: October 12, 1999
    Assignee: Vide Pharmaceuticals
    Inventors: Nino Sorgente, Charles Bakhit
  • Methods and compositions for ATP-sensitive K.sup.+ channel inhibition for lowering intraocular pressure
    Patent number: 5629345
    Abstract: ATP-sensitive K.sup.+ channel modulating compounds are incorporated into ophthalmically acceptable carriers for administration to the eye in order to affect intraocular pressure. Such formulations including compounds which inhibit the channel are particularly suitable for treating glaucoma and other disorders related to elevated intraocular pressure. Such formulation which potentiates the channel are particularly suitable for treating hypotonia and other depressed intraocular pressure conditions.
    Type: Grant
    Filed: July 23, 1993
    Date of Patent: May 13, 1997
    Assignee: Vide Pharmaceuticals
    Inventors: Nino Sorgente, Charles Bakhit